These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8476435)

  • 41. Apo-dystrophin-1 and apo-dystrophin-2, products of the Duchenne muscular dystrophy locus: expression during mouse embryogenesis and in cultured cell lines.
    Schofield JN; Blake DJ; Simmons C; Morris GE; Tinsley JM; Davies KE; Edwards YH
    Hum Mol Genet; 1994 Aug; 3(8):1309-16. PubMed ID: 7987307
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Specificity of expression of the muscle and brain dystrophin gene promoters in muscle and brain cells.
    Barnea E; Zuk D; Simantov R; Nudel U; Yaffe D
    Neuron; 1990 Dec; 5(6):881-8. PubMed ID: 2268434
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Application of in vitro Myo-differentiation of non-muscle cells to enhance gene expression and facilitate analysis of muscle proteins.
    Roest PA; van der Tuijn AC; Ginjaar HB; Hoeben RC; Hoger-Vorst FB; Bakker E; den Dunnen JT; van Ommen GJ
    Neuromuscul Disord; 1996 May; 6(3):195-202. PubMed ID: 8784808
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dystrophin is transcribed in brain from a distant upstream promoter.
    Boyce FM; Beggs AH; Feener C; Kunkel LM
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1276-80. PubMed ID: 1996328
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Localization of dystrophin gene transcripts during mouse embryogenesis.
    Houzelstein D; Lyons GE; Chamberlain J; Buckingham ME
    J Cell Biol; 1992 Nov; 119(4):811-21. PubMed ID: 1429837
    [TBL] [Abstract][Full Text] [Related]  

  • 46. RT-PCR isotyping of murine Ig-secreting cell lines.
    Popov AV; Fegeding KV; Sudarikov AB
    Biotechniques; 1995 Apr; 18(4):628-31. PubMed ID: 7598895
    [No Abstract]   [Full Text] [Related]  

  • 47. Trans-activation of the murine dystrophin gene in human-mouse hybrid myotubes.
    Noursadeghi M; Walsh FS; Heiman-Patterson T; Dickson G
    FEBS Lett; 1993 Apr; 320(2):155-9. PubMed ID: 8458432
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression and regulation of the dystrophin Purkinje promoter in human skeletal muscle, heart, and brain.
    Holder E; Maeda M; Bies RD
    Hum Genet; 1996 Feb; 97(2):232-9. PubMed ID: 8566960
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alternative splicing of dystrophin exon 4 in normal human muscle.
    Torelli S; Muntoni F
    Hum Genet; 1996 Apr; 97(4):521-3. PubMed ID: 8834255
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular characterization of further dystrophin gene microsatellites.
    King SC; Roche AL; Passos-Bueno MR; Takata R; Zatz M; Cockburn DJ; Seller A; Stapleton PM; Love DR
    Mol Cell Probes; 1995 Oct; 9(5):361-70. PubMed ID: 8569778
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitative estimation of minor mRNAs by cDNA-polymerase chain reaction. Application to dystrophin mRNA in cultured myogenic and brain cells.
    Chelly J; Montarras D; Pinset C; Berwald-Netter Y; Kaplan JC; Kahn A
    Eur J Biochem; 1990 Feb; 187(3):691-8. PubMed ID: 2406139
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stability of the human dystrophin transcript in muscle.
    Tennyson CN; Shi Q; Worton RG
    Nucleic Acids Res; 1996 Aug; 24(15):3059-64. PubMed ID: 8760894
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dystrophin isoforms expressed in the mouse retina.
    Tamura T; Yoshioka K; Jinno Y; Niikawa N; Miike T
    J Neurol Sci; 1993 Apr; 115(2):214-8. PubMed ID: 8482981
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of the dystrophin gene in mouse and rat brain.
    Gorecki D; Geng Y; Thomas K; Hunt SP; Barnard EA; Barnard PJ
    Neuroreport; 1991 Dec; 2(12):773-6. PubMed ID: 1793820
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of dystrophin mRNA and the protein in the developing rat heart.
    Tanaka H; Ozawa E
    Biochem Biophys Res Commun; 1990 Oct; 172(2):824-9. PubMed ID: 1700710
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Striking conservation of the brain-specific region of the dystrophin gene.
    Hugnot JP; Gilgenkrantz H; Jeanpierre M; Chelly J; Kaplan JC; Kahn A
    Mamm Genome; 1993; 4(7):393-6. PubMed ID: 8358174
    [No Abstract]   [Full Text] [Related]  

  • 57. Cardioprotective Effects of Hydrogen Sulfide and Its Potential Therapeutic Implications in the Amelioration of Duchenne Muscular Dystrophy Cardiomyopathy.
    Łoboda A; Dulak J
    Cells; 2024 Jan; 13(2):. PubMed ID: 38247849
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of Different Types of Corticosteroids on Heart Rate Variability of Individuals with Duchenne Muscular Dystrophy-A Pilot Cross Sectional Study.
    Dias RM; Hoshi RA; Vanderlei LCM; Monteiro CBM; Alvarez MPB; Crocetta TB; Grossklauss LF; Fernani DCGL; Dantas MTAP; Martins FPA; Garner DM; Abreu LC; Ferreira C; da Silva TD
    Life (Basel); 2021 Jul; 11(8):. PubMed ID: 34440496
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Age-Dependent Dysregulation of Muscle Vasculature and Blood Flow Recovery after Hindlimb Ischemia in the
    Podkalicka P; Mucha O; Kaziród K; Bronisz-Budzyńska I; Ostrowska-Paton S; Tomczyk M; Andrysiak K; Stępniewski J; Dulak J; Łoboda A
    Biomedicines; 2021 Apr; 9(5):. PubMed ID: 33925757
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future.
    Łoboda A; Dulak J
    Pharmacol Rep; 2020 Oct; 72(5):1227-1263. PubMed ID: 32691346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.